Elagolix monotherapy Safe Against Heavy Menstrual Bleeding associated with Uterine Leiomyomas
A new phase 4 study published in The Journal of Obstetrics and Gynecology found elagolix 150 mg monotherapy taken once-daily to solve heavy menstrual bleeding associated with uterine leiomyomas were the safe and effective. This offers promise to premenopausal patients aged 18–51 years. This randomized, double-blind, placebo-controlled study assessed a total of 82 patients, with […]